219935-32-7 Usage
Uses
Used in Pharmaceutical Industry:
3-(2-Morpholin-4-yl-ethoxy)-benzoic acid is used as a building block for the synthesis of various pharmaceuticals due to its unique chemical structure and properties. Its antifungal and antibacterial characteristics make it a promising candidate for the development of new drugs to combat infections.
Used in Agrochemical Industry:
In the agrochemical sector, 3-(2-Morpholin-4-yl-ethoxy)-benzoic acid is utilized as a component in the formulation of products designed to protect crops from fungal and bacterial diseases, thereby enhancing agricultural productivity.
Used in Drug Delivery Systems:
3-(2-Morpholin-4-yl-ethoxy)-benzoic acid is employed in drug delivery systems to improve the efficacy and targeted delivery of pharmaceutical agents. Its incorporation can potentially enhance the bioavailability and therapeutic outcomes of various drugs.
Used as a Pharmaceutical Intermediate:
As a pharmaceutical intermediate, 3-(2-Morpholin-4-yl-ethoxy)-benzoic acid plays a crucial role in the synthesis of complex drug molecules. Its presence in the chemical pathway allows for the creation of a wide range of medicinal compounds with diverse therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 219935-32-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,9,3 and 5 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 219935-32:
(8*2)+(7*1)+(6*9)+(5*9)+(4*3)+(3*5)+(2*3)+(1*2)=157
157 % 10 = 7
So 219935-32-7 is a valid CAS Registry Number.
219935-32-7Relevant academic research and scientific papers
ASK1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES
-
, (2012/06/30)
This invention relates to pyrrolopyrimidine derivatives of formula (I): where R1, X, p, R4, R2and R3are as defined herein, and their use as pharmaceuticals.
4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives
-
Page/Page column 60, (2010/11/26)
The present invention relates to compounds of the formula medicaments containing them and the use of these compounds as pharmaceutically active agents. The compounds exhibit activity as Raf kinase inhibitors and therefore may be useful for the treatment of diseases mediated by said kinases, especially as anticancer agents.
